| 12365656 |
Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Randall R. Miller, Joseph A. Kozlowski, Philippe G. Nantermet, David B. Olsen, Lihu Yang +4 more |
2025-07-22 |
|
| 12319671 |
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
Hua Zhou, John J. Acton, III, Michael J. Ardolino, Yi-Heng Chen, Peter H. Fuller +15 more |
2025-06-03 |
|
| 12180226 |
Spirotricycle RIPK1 inhibitors and methods of uses thereof |
Abdelghani Achab, Zachary G. Brill, Jenny Lorena Rico Duque, Xavier Fradera, Joey L. Methot +3 more |
2024-12-31 |
$180,761,000 |
| 12077591 |
TrkA antibody and application thereof |
Xiaoming GUAN, Chen Lv, Bai LU, Gang Lu, Jun ZHOU +2 more |
2024-09-03 |
|
| 11932637 |
Chromane amidine monobactam compounds for the treatment of bacterial infections |
Helen Chen, Shuzhi Dong, Zhiyong Hu, Tao Yu, Yong Zhang |
2024-03-19 |
$351,903,000 |
| 11752128 |
Benzimidazoles and indoles as taro inhibitors |
John P. Caldwell, Ginny D. Ho, Sookhee Nicole Ha, Sandra J. Koseoglu, Marc A. Labroli +11 more |
2023-09-12 |
$1,587,143,000 |
| 11738010 |
Oxazolidinones as TarO inhibitors |
John P. Caldwell, Reynalda De Jesus, Fa-Xiang Ding, Charles J. Gill, Ginny D. Ho +13 more |
2023-08-29 |
$257,779,000 |
| 11141403 |
Benzimidazoles and indoles as taro inhibitors |
John P. Caldwell, Ginny D. Ho, Sookhee Nicole Ha, Sandra J. Koseoglu, Marc A. Labroli +11 more |
2021-10-12 |
$185,365,000 |
| 11141410 |
Oxazolidinones as taro inhibitors |
John P. Caldwell, Reynalda De Jesus, Fa-Xiang Ding, Charles J. Gill, Ginny D. Ho +13 more |
2021-10-12 |
$185,365,000 |
| 11105818 |
MIC-1 receptor and uses thereof |
Wei Yang, Chih-Chuan Chang, Li Yang, Zhe SUN, Haibin Chen +3 more |
2021-08-31 |
$34,789,000 |
| 11072601 |
μ-opioid receptor agonist and preparation method therefor and use thereof in field of medicine |
Xin Xu, Zhen Zhang, Yunfei Li, Liming Zhang, Fengying Guo +8 more |
2021-07-27 |
|
| 11000603 |
Multi-specific binding conjugate, related pharmaceutical compositions and use |
Haoyang Yu, Zhengcheng LI |
2021-05-11 |
|
| 10947205 |
Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Mihir Mandal, David B. Olsen, Lihu Yang, Katherine Young, Takao Suzuki +1 more |
2021-03-16 |
$129,391,000 |
| 10758625 |
Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereof |
Haoyang Yu, Zhengcheng LI |
2020-09-01 |
|
| 10752621 |
Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Lihu Yang, Takao Suzuki |
2020-08-25 |
$403,892,000 |
| 10144741 |
Nargenicin compounds and uses thereof as antibacterial agents |
Katherine Young, David B. Olsen, Sheo B. Singh, Robert R. Wilkening, James M. Apgar +7 more |
2018-12-04 |
$303,886,000 |
| 9944654 |
Nargenicin compounds and uses thereof as antibacterial agents |
Katherine Young, David B. Olsen, Sheo B. Singh, Robert R. Wilkening, James M. Apgar +7 more |
2018-04-17 |
$82,364,000 |
| 9839642 |
Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors |
Haifeng Tang, Shu-Wei Yang, Mihir Mandal, Guoqing Li, Weidong Pan +10 more |
2017-12-12 |
$85,898,000 |
| 9708336 |
Metallo-beta-lactamase inhibitors |
Mihir Mandal, Haifeng Tang, Li Xiao, Guoqing Li, Shu-Wei Yang +18 more |
2017-07-18 |
$61,300,000 |
| 9636374 |
pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics |
Phillip B. Messersmith, Vincent L. Cryns |
2017-05-02 |
|
| 9422368 |
Humanized anti-human NKG2A monoclonal antibody |
Petrus Johannes Louis Spee, Jianhe Chen, Soren Padkjaer, Jinchao ZHANG, Jiujiu Yu |
2016-08-23 |
$25,161,000 |
| 9034829 |
pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics |
Phillip B. Messersmith, Vincent L. Cryns |
2015-05-19 |
|
| 9012594 |
Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors |
Phillip B. Messersmith, Bi-Huang Hu |
2015-04-21 |
|
| 8841408 |
Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation |
Phillip B. Messersmith, Bi-Huang Hu |
2014-09-23 |
|
| 8796427 |
Humanized anti-human NKG2A monoclonal antibody |
Petrus Johannes Louis Spee, Jianhe Chen, Søren Berg Padkjær, Jinchao ZHANG, Jiujiu Yu |
2014-08-05 |
$18,372,000 |
